{"count": 2, "results": [{"_id": "23228442", "pmid": 23228442, "title": "Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin.", "journal": "Eur J Cancer", "authors": ["Yang J", "Kalogerou M", "Gallacher J", "Sampson JR", "Shen MH"], "date": "2013-04-01T00:00:00Z", "doi": "10.1016/j.ejca.2012.10.027", "meta_date_publication": "2013 Apr", "meta_volume": "49", "meta_issue": "6", "meta_pages": "1479-90", "score": 50040.45, "text_hl": "These observations suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could have therapeutic potential for @DISEASE_Tuberous_Sclerosis @DISEASE_MESH:D014402 @@@tuberous sclerosis@@@, an @<m>DISEASE_Genetic_Diseases_Inborn</m> @DISEASE_MESH:D030342 @@@inherited disorder@@@ characterised by the aberrant activation of mTORC1 and the development of @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumours@@@ in many organs, including the kidneys. ", "citations": {"NLM": "Yang J, Kalogerou M, Gallacher J, Sampson JR, Shen MH. Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin. Eur J Cancer. 2013 Apr;49(6):1479-90. PMID: 23228442", "BibTeX": "@article{23228442, title={Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin.}, author={Yang J and Kalogerou M and Gallacher J and Sampson JR and Shen MH}, journal={Eur J Cancer}, volume={49}, number={6}, pages={1479-90}}"}}, {"_id": "26655904", "pmid": 26655904, "pmcid": "PMC4779191", "title": "The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis", "journal": "Cell Rep", "authors": ["Joshi S", "Tolkunov D", "Aviv H", "Hakimi AA", "Yao M", "Hsieh JJ", "Ganesan S", "Chan CS", "White E"], "date": "2015-12-01T00:00:00Z", "doi": "10.1016/j.celrep.2015.10.059", "meta_date_publication": "2015 Dec 1", "meta_volume": "13", "meta_issue": "9", "meta_pages": "1895-908", "score": 50030.723, "text_hl": "This suggests that the @<m>DISEASE_Genetic_Diseases_Inborn</m> @DISEASE_MESH:D030342 @@@genetic defects@@@ in mitochondria activate a metabolic checkpoint, producing autophagy impairment and @DISEASE_Mitochondrial_Diseases @DISEASE_MESH:D028361 @@@mitochondrial accumulation@@@ that limit @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ progression, revealing a novel @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@-suppressive mechanism for mitochondrial inhibition with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Joshi S, Tolkunov D, Aviv H, Hakimi AA, Yao M, Hsieh JJ, Ganesan S, Chan CS, White E. The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis Cell Rep. 2015 Dec 1;13(9):1895-908. PMID: 26655904", "BibTeX": "@article{26655904, title={The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis}, author={Joshi S and Tolkunov D and Aviv H and Hakimi AA and Yao M and Hsieh JJ and Ganesan S and Chan CS and White E}, journal={Cell Rep}, volume={13}, number={9}, pages={1895-908}}"}}]}